Results 21 to 30 of about 16,099 (284)
Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma-Factor analysis.
Allergy. European Journal of Allergy and Clinical Immunology, 2023 BACKGROUND Allergic bronchopulmonary aspergillosis (ABPA) develops in the presence or absence of asthma, either atopic or nonatopic. We have tried to explore the essential components in the pathogenesis of the disease, which are either consistent and ...
N. Okada +19 more
semanticscholar +1 more source
Allergic Bronchopulmonary Aspergillosis [PDF]
Allergy & Clinical Immunology International - Journal of the World Allergy Organization, 2005 Allergic bronchopulmonary aspergillosis (ABPA) is an immunologically mediated lung disease which occurs predominantly in patients with asthma, and is caused by hypersensitivity to colonized Aspergillus fumigatus. It is a chronic, relapsing disorder which can clinically range from mild asthma to fibrotic lung disease.
I, Tillie-Leblond, A-B, Tonnel
openaire +4 more sources
Frontiers in Cellular and Infection Microbiology, 2022 Background The modified International Society for Human and Animal Mycology (ISHAM) allergic bronchopulmonary aspergillosis (ABPA) working group (AWG) criteria lists up to five components for diagnosing ABPA in asthmatics.
R. Agarwal +7 more
semanticscholar +1 more source
Journal of Respiration, 2022 Aspergillus fumigatus can cause an immunological hypersensitivity reaction known as allergic bronchopulmonary aspergillosis (ABPA), which often worsens asthma and cystic fibrosis patients’ conditions.
Aman Nagar +4 more
doaj +1 more source
European Respiratory Review, 2022 Background Aspergillus fumigatus is a common saprophytic fungus causing allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis (CF).
S. Manti +7 more
semanticscholar +1 more source
Critical asthma associated with allergic bronchopulmonary aspergillosis: Case report
Revista Peruana de Medicina Experimental y Salud Pública, 2020 Critical asthma syndrome is the most severe consequence of an acute asthma exacerbation. Allergic bronchopulmonary aspergillosis is one of the most frequent pathologies that mimic critical asthma syndrome and is associated with a high mortality risk when
Miguel A. Vences +4 more
doaj +1 more source
Journal of Association of Pulmonologist of Tamil Nadu, 2021 In the midst of COVID pandemic, all cases presenting with lung infiltrates are assumed to be covid. However, other diagnoses are possible and a case of allergic bronchopulmonary aspergillosis which presented in the midst of the pandemic is highlighted ...
Vinod Kumar Viswanathan
doaj +1 more source
Internal medicine, 2021 A 45-year-old man with allergic bronchopulmonary aspergillosis (ABPA) was treated with oral prednisolone (PSL) (30 mg/day), inhaled corticosteroids, and long-acting beta2-agonists.
Sunao Mikura +11 more
semanticscholar +1 more source
Dupilumab: a new contestant to corticosteroid in allergic bronchopulmonary aspergillosis
Oxford Medical Case Reports, 2021 Allergic bronchopulmonary aspergillosis (ABPA) is a disease characterized by severe disability with recurrent wheezing and shortness of breath. The current recommended therapy is daily oral corticosteroids +/− oral antifungal therapy.
Muhammad Ali, O'Neil Green
semanticscholar +1 more source
Allergic bronchopulmonary aspergillosis: diagnostic and treatment challenges [PDF]
, 2016 Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder, occurring mostly in asthmatic and cystic fibrosis patients, caused by an abnormal T-helper 2 lymphocyte response of the host to Aspergillus fumigatus antigens.
CINICOLA, BIANCA LAURA +3 more
core +1 more source